Induction of APOBEC3G in human hepatoma cells by interferon-α stimulation

来源 :Journal of Microbiology and Immunology | 被引量 : 0次 | 上传用户:cxg2009
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
To clarify the role of APOBEC3G (A3G) in cellular defense against hepatitis B virus ( HBV), the expression of A3G in normal human liver and the regulation of the A3G expression in hep-atoma cell line (HuH-7) were investigated. Expression level of APOBEC3s mRNA in human liver was determined by RT-PCR. HuH-7 and HepG2 cells were treated with various concentrations of IFN-α(0 U/ml, 100 U/ml, 500 U/ml, 1000 U/ml)for 12 h. The mRNA levels were measured by a quantitative RT-PCR, the results were normalized relative to the specimens without IFN-αstimulation. Total protein of HuH-7 cells treated with various concentrations of IFN-αfor 48 h was subjected to Western blot analysis. For reporter gene assay, HuH-7 cells were transfected with the reporter plasmids containing IRF-E sites and its mutants with different lengths. Then the cells were treated with or without 1200 U/ml IFN-a for additional 12 h (1000 U/ml) after 24 h of transfection, and the cell lysate was prepared and assayed for luciferase activity. It was found that normal human liver expressed the mRNA of A3G. A3G mRNA expression in HuH-7 and HepG2 cells were up-regulated by IFN-αstimulation in a dose-depen-dent manner. Western blot analysis indicated that A3G protein expression was also enhanced by IFN-αstimulation. Sequence analysis showed the existence of putative sites of IFN regulatory factor element (IRF-E) in 5’ region of A3G gene upstream the initiation codon. IFN-αstimulation results in 6- to 8-fold increase in luciferase activity in cells transfected with the plasmid containing IRF-E sites of the 5’ upstream sequences, whereas luciferase activity did not change in cells transfected with the plasmid containing mutant IRF-E sites or without IRF-E sites. As a conclusion, A3G are expressed in normal human liver. A3G expression was up-regulated by IFN-αstimulation in hepatoma cells and could be involved in host defense mechanisms against HBV. ERF-E site in 5’ region of AP0BEC3G gene upstream the initiation codon plays an important role in this process. To clarify the role of APOBEC3G (A3G) in cellular defense against hepatitis B virus (HBV), the expression of A3G in normal human liver and the regulation of the A3G expression in hep-atoma cell line (HuH-7) were investigated. Expression level of APOBEC3s mRNA in human liver was determined by RT-PCR. HuH-7 and HepG2 cells were treated with various concentrations of IFN-α (0 U / ml, 100 U / ml, 500 U / ml, 1000 U / ml) for 12 h. The mRNA levels were measured by a quantitative RT-PCR, the results were normalized relative to the specimens without IFN-αstimulation. Total protein of HuH-7 cells treated with various concentrations of IFN-αfor 48 h was subjected to Western blot analysis. For reporter gene assay, HuH-7 cells were transfected with the reporter plasmids containing IRF-E sites and its mutants with different lengths. Then the cells were treated with or without 1200 U / ml IFN-a for additional 12 h ( 1000 U / ml) after 24 h of transfection, and the cell lysate was prepared and assayed for luci It was found that normal human liver expressed the mRNA of A3G. A3G mRNA expression in HuH-7 and HepG2 cells were up-regulated by IFN-αstimulation in a dose-dependent-dent manner. Western blot analysis showed that A3G protein expression was also enhanced by IFN-αstimulation. Sequence analysis showed the existence of putative sites of IFN regulatory factor element (IRF-E) in 5 ’region of A3G gene upstream the initiation codon. IFN-αstimulation results in 6- to 8-fold increase in luciferase activity in cells transfected with the plasmid containing IRF-E sites of the 5 ’downstream sequences, whereas luciferase activity did not change in cells transfected with the plasmid containing mutant IRF-E sites or without IRF-E sites. A3G expression was up-regulated by IFN-αstimulation in hepatoma cells and could be involved in host defense mechanisms against HBV. A3G expression was up-regulated by IFN-αstimulation in hepatoma cells and HBV may be involved in host defense mechanisms against HBV. ion codon plays an important role in this process.
其他文献
Systematic Ce anomalies for whole-rock have been obtained from the shale-dominated, continuous, and pelagic sedimentary sequences spanning the Ordovician/Siluri
目的 探讨新辅助化疗在治疗Ⅲ期非小细胞肺癌(NSCLC)中的应用价值.方法 经病理检查确诊的65例Ⅲ期初治NSCLC患者,于手术前随机分成两组,即新辅助化疗+手术治疗组(试验组)30例和单纯手术组(对照组)35例,观察新辅助化疗对肿瘤患者的缓解率和毒副反应,对比手术治疗后两组的远期疗效.结果 试验组化疗总有效率为73.33%,化疗反应患者可耐受.试验组手术切除率89.66%,对照组为80.00%,
目的 探讨新辅助化疗联合股四头肌间室切除及功能重建术治疗股四头肌恶性纤维组织细胞瘤(MFH)的方法和效果.方法 27例MFH患者,其中初治患者17例,复发病例10例,均行新辅助化疗与股四头肌间室切除及功能重建术.结果 均予保留患肢,随访18~66个月.局部复发0例,5年生存21例(78%),其中无瘤生存18例(67%).结论 新辅助化疗联合股四头肌间室切除及功能重建术治疗MFH效果满意。
Background/Aims:Liver transplantation is an effective treatment for highly selected patients with hepatocellular carcinoma(HCC) ,but tumour recurrence remains a
High-throughput SNP detection microarrays were used here to explore the relationship between 5, 10-methylenetetrahydrofolate reductase (MTHFR) gene polymorphism
患者男,62岁.因体检发现右肾占位于2005年12月9日入院.患者无发热、腰痛、血尿等异常症状.B超检查发现右肾体积增大,上极实质内见一囊实性包块,向外突起,大小约6.5 cm×5.5 cm,边界尚清,内可见多条分隔.CT显示右肾上极有一6.5 cm×5.8 cm的类圆形低密度影,CT值17Hu,加强CT值71 Hu,内见明显网状分隔.体检:腹部未扪及包块,双肾区无叩痛,双侧输尿管区无压痛.临床诊
转化生长因子(TGFβ)是一类有多种生物学功能的生长因子,可抑制上皮细胞生长.转化生长因子βⅠ型受体(TβRⅠ)在TGFβ信号传递中不可缺少,否则TGFβ无法实现其功能[1]。
患者 女,20岁.前额肿块近2年,加重伴双侧眼睑肿胀1个月余.体检:前额部局限性隆起,无压痛,不活动,表面皮肤无红肿溃破,视乳头水肿。
患者男,51岁.因声音嘶哑3个月于外院就诊.电子喉镜检查示右侧声带表面弥漫乳头状新生物,声带活动好.2005年2月16日活检病理报告示鳞状细胞癌伴坏死。
Magnetic resonance imaging (MRI) findings in three patients with primary anorectal malignant melanoma are described. Two patients had melanotic and one had amel